• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Helus Pharma Inc. - Common Stock (NQ:HELP)

    10.94 UNCHANGED
    Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,006
    Open 10.94
    Bid (Size) 11.00 (500)
    Ask (Size) 11.47 (100)
    Prev. Close 10.94
    Today's Range 10.94 - 10.94
    52wk Range 3.760 - 15.15
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MissionIRNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints CNS Drug Development Veteran Suresh Durgam to Board of Directors
    Via Investor Brand Network
    News headline image
    Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
    From Helus Pharma Inc.
    Via GlobeNewswire

    Performance

    52-Week Range 27.8% below 52-week high
    10.94
    3.7652W Low 15.1552W High
    1 Week 6.8% below 1-week high
    10.131W Low 11.741W High

    Helus Pharma Inc. - Common Stock (HELP) traded between $3.76 and $15.15 over the past 52 weeks and last traded at $10.94, 27.8% below its 52-week high. Over the past week it ranged between $10.13 and $11.74.

    Past 12 Months
    +5.4%
    -19.9%
    +35.1%
    +121.9%
    +41.5%
    +41.5%
    1W +$0.56
    1M -$2.72
    3M +$2.84
    6M +$6.01
    YTD +$3.21
    1Y +$3.21

    HELP was +41.5% over the past year, +121.9% over six months, +41.5% year to date, +5.4% in the last week.

    12 Months vs Market
    HELP
    +41.5%
    DIA
    +12.3%
    SPY
    +14.6%
    QQQ
    +17.3%
    IWM
    +11.1%

    Over the past 12 months HELP returned +41.5% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

    Volume & Liquidity 0.00× 3-mo avg
    Today 1,006 3-mo avg 1.8M
    1W
    1.4M
    1M
    1.6M
    3M
    1.8M
    6M
    1.5M
    YTD
    1.3M
    1Y
    1.3M

    HELP most recently traded 1,006 shares against a 3-month average daily volume of 1.8M.

    More News

    Read More
    BioMedNewsBreaks — Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) to Host Investor Presentation Highlighting Depression and Anxiety Treatment Programs on Oct. 21
    Via Investor Brand Network
    News headline image
    Helus Pharma to Host Investor Presentation on October 21, 2026
    From Helus Pharma Inc.
    Via GlobeNewswire
    MissionIRNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Changes Legal Name from Cybin Inc.
    Via Investor Brand Network
    TinyGemsBreaks – Helus Pharma (TM) (NASDAQ: HELP) (Cboe CA: HELP) Advances HLP003 Phase 3 Program, Targets Q4 2026 Topline Data
    Via Investor Brand Network
    News headline image
    Helus Pharma Announces Completion of Legal Name Change
    From Helus Pharma
    Via GlobeNewswire
    News headline image
    Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression ↗
    Via MarketBeat
    NetworkNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Reports Annual and Special Meeting Results, Legal Name Change Effective Oct. 1
    Via Investor Brand Network
    News headline image
    Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
    From Helus Pharma
    Via GlobeNewswire
    NetworkNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in TD Cowen Neuropsychiatry Summit
    Via Investor Brand Network
    News headline image
    Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board ↗
    Via MarketBeat
    News headline image
    Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
    From Helus Pharma
    Via GlobeNewswire
    PsychedelicNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Presents HLP003 Data From MDD Program at Psych Congress 2026
    Via Investor Brand Network
    News headline image
    Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
    From Helus Pharma
    Via GlobeNewswire
    News headline image
    Cybin Eyes Q4 Phase 3 Data for Depression Drug HLP003 ↗
    Via MarketBeat
    News headline image
    Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances ↗
    Via MarketBeat
    BioMedNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in Morgan Stanley Global Healthcare Conference
    Via Investor Brand Network
    News headline image
    Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
    From Helus Pharma
    Via GlobeNewswire
    InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in H.C. Wainwright 28th Annual Global Investment Conference
    Via Investor Brand Network
    News headline image
    Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
    From Helus Pharma
    Via GlobeNewswire
    PsychedelicNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) to Participate in Cantor Global Healthcare Conference
    Via Investor Brand Network
    News headline image
    Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
    From Helus Pharma
    Via GlobeNewswire
    InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Regina Donohue Chief People Officer and Suresh Durgam to Scientific Advisory Board
    Via Investor Brand Network
    News headline image
    Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
    From Helus Pharma
    Via GlobeNewswire

    Frequently Asked Questions

    Is Helus Pharma Inc. - Common Stock publicly traded?
    Yes, Helus Pharma Inc. - Common Stock is publicly traded.
    What exchange does Helus Pharma Inc. - Common Stock trade on?
    Helus Pharma Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Helus Pharma Inc. - Common Stock?
    The ticker symbol for Helus Pharma Inc. - Common Stock is HELP on the Nasdaq Stock Market
    What is the current price of Helus Pharma Inc. - Common Stock?
    The current price of Helus Pharma Inc. - Common Stock is 10.94
    When was Helus Pharma Inc. - Common Stock last traded?
    The last trade of Helus Pharma Inc. - Common Stock was at 10/20/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.